Navidea Biopharmaceuticals, Inc. (NAVB) News
Filter NAVB News Items
NAVB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest NAVB News From Around the Web
Below are the latest news stories about NAVIDEA BIOPHARMACEUTICALS INC that investors may wish to consider to help them evaluate NAVB as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayPre-market stock movers are a hot topic on Tuesday as investors seek out the latest news on the biggest gainers and losers this morning! |
Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelDUBLIN, Ohio, August 10, 2023--Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel |
Why Is Navidea Biopharmaceutical (NAVB) Stock Down 13% Today?Navidea Biopharmaceutical (NAVB) stock is falling on Monday after the biopharmaceutical company got a major delisting warning. |
Why Is SOFI Stock Up 19% Today?SoFi Technologies (SOFI) stock is on the rise Monday after the financial services company released results for the second quarter of 2023. |
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning! |
Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces OpportunitiesDUBLIN, Ohio, July 31, 2023--Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities. |
Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American DeterminationDUBLIN, Ohio, July 29, 2023--Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination. |
Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial OfficerDUBLIN, Ohio, July 27, 2023--Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer |
Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps DownDUBLIN, Ohio, July 13, 2023--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced Dana J Moss, JD has joined the Company’s Board of Directors, adding depth in legal advice, strategic business, life sciences and technology in line with Navidea’s stated objectives and its Fix, Fund, Propel approach to advancing innovative technology to market. Separately |